FMI
GILD icon

F/M Investments’s Gilead Sciences GILD Stock Holding History

F/M Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Hold
2,163
– – 0.01% 315
2026
Q1 		$301K Hold
2,163
– – 0.02% 290
2025
Q4 		$266K Hold
2,163
– – 0.01% 401
2025
Q3 		$240K Buy
2,163
+1
+0% +$114 0.01% 391
2025
Q2 		$240K Sell
2,162
-287
-12% -$30.5K 0.01% 380
2025
Q1 		$274K Sell
2,449
-2
-0.1% -$206 0.01% 365
2024
Q4 		$226K Sell
2,451
-84
-3% -$7.56K 0.01% 387
2024
Q3 		$212K Buy
+2,535
New +$193K 0.01% 332
2021
Q2 		– Sell
-4,042
Closed -$261K – 82
2021
Q1 		$261K Buy
+4,042
New +$261K 0.21% 65

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

F/M Investments's GILD Position: Q2 2026 in Review

F/M Investments held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,163 shares worth $273K. The position accounts for 0.01% of the portfolio, ranked #315.

F/M Investments first reported a position in GILD in Q1 2021 and has held it in 9 quarters since. The position peaked at $301K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • F/M Investments held 2,163 shares of Gilead Sciences worth $273K as of Q2 2026.
  • F/M Investments left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.01% of F/M Investments's portfolio in Q2 2026, its #315 holding.
  • F/M Investments first reported a position in Gilead Sciences in Q1 2021 and has held it in 9 quarters since.
  • F/M Investments's Gilead Sciences position peaked at $301K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.